Telix Pharmaceuticals Limited American Depositary Shares Earnings Dividend

Telix Pharmaceuticals Limited American Depositary Shares’s revenue jumped 755.13% since last year same period to $1.67Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -74.78% fall in its revenue since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s net profit fell -102.52% since last year same period to $-17.5Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -14530.68% fall in its net profits since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s net profit margin jumped 76.32% since last year same period to -1049.33% in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Limited American Depositary Shares has generated -57326.66% fall in its net profit margins since last 3-months.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a 0% jump from last quarter’s estimates.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current year stand at -0.01.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) fell -33.33% since last year same period to 0.04 in the Q4 2025. This indicates that the Telix Pharmaceuticals Limited American Depositary Shares has generated -33.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.